How many institutions held AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value in Q3 2023?

194 institutional investors reported AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value for Q3 2023. Use the holders table for investor-level position and value details.

Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)

Q: What does CUSIP 05156V102 represent in this 13F holders report?

CUSIP 05156V102 is the security identifier for AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value used to aggregate holder disclosures.

CUSIP: 05156V102

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class: Equity / Common Shares, no par value
Shares outstanding: 132,929,348
Total 13F shares: 50,339,448
Share change: +483,358
Total reported value: $391,141,750
Put/Call ratio: 56%
Price per share: $7.77
Number of holders: 194
Value change: -$739,167
Number of buys: 91
Number of sells: 70

Quarterly Holders Quick Answers

What is CUSIP 05156V102?
CUSIP 05156V102 identifies AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2023
Previous quarter: Q2 2023

Recent filing periods for CUSIP 05156V102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	6.3%	8,333,034	$80,663,770	—	30 Jun 2023	13F
ARMISTICE CAPITAL, LLC	13F	Company	3.5%	4,692,000	$45,418,560	—	30 Jun 2023	13F
NEA Management Company, LLC	13F	Company	3%	3,969,834	$38,427,993	—	30 Jun 2023	13F
STATE STREET CORP	13F	Company	2%	2,632,486	$25,482,464	—	30 Jun 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	1.3%	1,744,205	$16,883,904	—	30 Jun 2023	13F
MORGAN STANLEY	13F	Company	1.3%	1,685,786	$16,318,409	—	30 Jun 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	1.2%	1,530,400	$14,814,000	—	30 Jun 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.1%	1,410,766	$13,656,214	—	30 Jun 2023	13F
VANGUARD GROUP INC	13F	Company	1%	1,382,517	$13,382,764	—	30 Jun 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	1%	1,368,171	$13,243,895	—	30 Jun 2023	13F
NORTHERN TRUST CORP	13F	Company	0.76%	1,009,989	$9,776,693	—	30 Jun 2023	13F
Artal Group S.A.	13F	Company	0.75%	1,000,000	$9,680,000	—	30 Jun 2023	13F
CITIGROUP INC	13F	Company	0.68%	904,906	$8,759,490	—	30 Jun 2023	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.61%	805,534	$7,797,569	—	30 Jun 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.61%	804,486	$7,787,424	—	30 Jun 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.57%	760,100	$7,357,768	—	30 Jun 2023	13F
D. E. Shaw & Co., Inc.	13F	Company	0.46%	613,513	$5,938,806	—	30 Jun 2023	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	0.43%	573,530	$5,551,770	—	30 Jun 2023	13F
TIG Advisors, LLC	13F	Company	0.42%	561,096	$5,431,409	—	30 Jun 2023	13F
J. Goldman & Co LP	13F	Company	0.42%	552,407	$5,347,300	—	30 Jun 2023	13F
Point72 Asset Management, L.P.	13F	Company	0.41%	544,720	$5,272,890	—	30 Jun 2023	13F
Antara Capital LP	13F	Company	0.38%	500,000	$4,840,000	—	30 Jun 2023	13F
Woodline Partners LP	13F	Company	0.38%	500,000	$4,840,000	—	30 Jun 2023	13F
Rock Springs Capital Management LP	13F	Company	0.36%	479,540	$4,641,947	—	30 Jun 2023	13F
Liontrust Investment Partners LLP	13F	Company	0.32%	421,000	$4,075,280	—	30 Jun 2023	13F
Bank of New York Mellon Corp	13F	Company	0.3%	402,434	$3,895,561	—	30 Jun 2023	13F
JPMORGAN CHASE & CO	13F	Company	0.3%	392,418	$3,798,606	—	30 Jun 2023	13F
JANE STREET GROUP, LLC	13F	Company	0.28%	369,759	$3,579,267	—	30 Jun 2023	13F
GROUP ONE TRADING LLC	13F	Company	0.28%	367,093	$3,553,460	—	30 Jun 2023	13F
STIFEL FINANCIAL CORP	13F	Company	0.28%	366,021	$3,543,087	—	30 Jun 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.27%	361,998	$3,504,141	—	30 Jun 2023	13F
Trexquant Investment LP	13F	Company	0.24%	320,018	$3,097,774	—	30 Jun 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.23%	311,554	$3,015,843	—	30 Jun 2023	13F
Michael Robert Martin	3/4/5	Chief Business Officer	— class O/S missing	259,162	$2,918,164	—	02 Mar 2023	3/4/5
Swiss National Bank	13F	Company	0.21%	279,300	$2,703,624	—	30 Jun 2023	13F
NATIXIS	13F	Company	0.2%	262,256	$2,538,638	—	30 Jun 2023	13F
LEVEL FOUR ADVISORY SERVICES, LLC	13F	Company	0.19%	249,400	$2,414,192	—	30 Jun 2023	13F
UBS Group AG	13F	Company	0.18%	242,370	$2,346,142	—	30 Jun 2023	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.18%	241,740	$2,340,043	—	30 Jun 2023	13F
NORDEA INVESTMENT MANAGEMENT AB	13F	Company	0.16%	212,400	$2,121,876	—	30 Jun 2023	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.16%	213,216	$2,063,932	—	30 Jun 2023	13F
Jefferies Financial Group Inc.	13F	Company	0.15%	200,000	$1,936,000	—	30 Jun 2023	13F
RHUMBLINE ADVISERS	13F	Company	0.13%	179,126	$1,733,939	—	30 Jun 2023	13F
Advisory Services Network, LLC	13F	Company	0.13%	177,100	$1,714,328	—	30 Jun 2023	13F
SIMPLEX TRADING, LLC	13F	Company	0.13%	175,407	$1,697,000	—	30 Jun 2023	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.13%	168,595	$1,632,000	—	30 Jun 2023	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.11%	148,656	$1,629,270	—	30 Jun 2023	13F
CREDIT SUISSE AG/	13F	Company	0.12%	159,790	$1,546,768	—	30 Jun 2023	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.12%	157,959	$1,529,043	—	30 Jun 2023	13F
Parallax Volatility Advisers, L.P.	13F	Company	0.11%	150,952	$1,461,215	—	30 Jun 2023	13F

Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q3 2023

As of 30 Sep 2023, Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by 194 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 50,339,448 shares. The largest 10 holders included BlackRock Inc., ARMISTICE CAPITAL, LLC, NEA Management Company, LLC, STATE STREET CORP, Nuveen Asset Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, MORGAN STANLEY, and NORTHERN TRUST CORP. This page lists 195 institutional shareholders reporting positions in this security for the Q3 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders

197

Q3 2023 holders

194

Holder diff

-3

Investor	Q2 2023 Shares	Q3 2023 Shares	Share Diff	Share Chg %	Q2 2023 Value $	Q3 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.